{"id":832327,"date":"2025-04-01T11:00:33","date_gmt":"2025-04-01T15:00:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mayo-clinic-proceedings-publishes-new-global-insulin-injection-recommendations\/"},"modified":"2025-04-01T11:00:33","modified_gmt":"2025-04-01T15:00:33","slug":"mayo-clinic-proceedings-publishes-new-global-insulin-injection-recommendations","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mayo-clinic-proceedings-publishes-new-global-insulin-injection-recommendations\/","title":{"rendered":"Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations"},"content":{"rendered":"

\nFirst Update in Nearly 10 Years by FITTER Forward Initiative Sets Out to Transform Insulin Injection Technique Education
\n<\/h2>\n
\n

PARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark publication in the Mayo Clinic Proceedings. <\/em>The publication introduces the FITTER Forward Expert Recommendations<\/strong>, an updated set of global best practices for insulin injection technique and education. Authored by a panel of 16 diabetes specialists from 13 countries, the FITTER Forward initiative highlights the critical need for improved training and standardization in insulin delivery, aiming to enhance clinical outcomes for millions of people with diabetes worldwide.<\/p>\n

\u201cWhen physicians and nurses discuss insulin treatments, they usually focus on the specific dose, but not so much on how exactly the insulin is administered. However, proper injection technique, proper handling of injection devices, and proper insulin handling can all significantly improve long-term glycemic control,\u201d said Dr. David Klonoff, Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center, Clinical Professor of Medicine at UCSF, and lead author of the publication. \u201cHow insulin is injected actually plays a more crucial factor in maintaining target blood glucose levels than many realize. This new recommendation provides healthcare professionals with clear, evidence-based strategies to help ensure that insulin is delivered correctly and safely.”\u00a0<\/p>\n

The Forum for Injection Technique and Therapy Expert Recommendations (FITTER)<\/strong> was initially developed in 2016, brought together by embecta, then part of BD (Becton, Dickinson and Company), to guide insulin administration best practices. Since then, advancements in device technology, research, and real-world patient data have warranted a major update, including:<\/p>\n